...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    advb-img

    Advanced Biomed Inc. Common Stock, Common Stock

    ADVB

    NAQ

    $1.71

    -$0.09

    (-5%)

    1D

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $37.00M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     83.07K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $1.76 L
    $4.1 H
    $1.71

    About Advanced Biomed Inc. Common Stock, Common Stock

    Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, a fully automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cells (CTCs) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also provides microfluidic biochips comprising A+Pre, AC-1000 CTC Enrichment, and A+CellScan chips that are designed to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include the A+CTCE kit, which is used to identify epithelial circulating tumor cells and is determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; the A+CTCM kit, which is used to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; the A+EMT, which is used to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and the A+CM, which is used to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies. Further, the company is developing A+LCGuard for early screening of lung cancer. Additionally, it establishes and operates medical clinics in the People's Republic of China. The company was founded in 2014 and is headquartered in New York, New York. more

    Returns

    Data is not properly formatted.

    Financials

    Jun '21Jun '22Jun '23Jun '24
    Total Revenue----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Cost of Revenue----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Gross Profit----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Gross Margin----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Operating Expenses1.84M2.37M3.07M2.54M[{"date":"2021-06-30","value":59.81,"profit":true},{"date":"2022-06-30","value":77.31,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":82.75,"profit":true}]
    Operating Income(1.84M)(2.37M)(3.07M)(2.54M)[{"date":"2021-06-30","value":-183694000,"profit":false},{"date":"2022-06-30","value":-237437100,"profit":false},{"date":"2023-06-30","value":-307122300,"profit":false},{"date":"2024-06-30","value":-254157200,"profit":false}]
    Total Non-Operating Income/Expense(218.00)(1.65M)(661.55K)(240.71K)[{"date":"2021-06-30","value":-21800,"profit":false},{"date":"2022-06-30","value":-165335100,"profit":false},{"date":"2023-06-30","value":-66155400,"profit":false},{"date":"2024-06-30","value":-24070600,"profit":false}]
    Pre-Tax Income(1.84M)(4.03M)(3.73M)(2.78M)[{"date":"2021-06-30","value":-183715800,"profit":false},{"date":"2022-06-30","value":-402772200,"profit":false},{"date":"2023-06-30","value":-373277700,"profit":false},{"date":"2024-06-30","value":-278227800,"profit":false}]
    Income Taxes----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Income After Taxes----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Income From Continuous Operations(1.84M)(4.03M)(3.73M)(2.78M)[{"date":"2021-06-30","value":-183715800,"profit":false},{"date":"2022-06-30","value":-402772200,"profit":false},{"date":"2023-06-30","value":-373277700,"profit":false},{"date":"2024-06-30","value":-278227800,"profit":false}]
    Income From Discontinued Operations----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Net Income(1.84M)(4.03M)(3.73M)(2.78M)[{"date":"2021-06-30","value":-183715800,"profit":false},{"date":"2022-06-30","value":-402772200,"profit":false},{"date":"2023-06-30","value":-373277700,"profit":false},{"date":"2024-06-30","value":-278227800,"profit":false}]
    EPS (Diluted)----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    ADVB
    Current Ratio 0.95

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    ADVB
    ROA (LTM) 0.00%
    ROE (LTM) 0.00%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    ADVB
    Debt Ratio Lower is generally better. Negative is bad. 0.76
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.24

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    ADVB
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 0.00
    P/B 0.00
    EV/R 0.00
    EV/Ebitda NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Advanced Biomed Inc. Common Stock share price today?

    Advanced Biomed Inc. Common Stock (ADVB) share price today is $1.71

    Can Indians buy Advanced Biomed Inc. Common Stock shares?

    Yes, Indians can buy shares of Advanced Biomed Inc. Common Stock (ADVB) on Vested. To buy Advanced Biomed Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADVB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Advanced Biomed Inc. Common Stock be purchased?

    Yes, you can purchase fractional shares of Advanced Biomed Inc. Common Stock (ADVB) via the Vested app. You can start investing in Advanced Biomed Inc. Common Stock (ADVB) with a minimum investment of $1.

    How to invest in Advanced Biomed Inc. Common Stock shares from India?

    You can invest in shares of Advanced Biomed Inc. Common Stock (ADVB) via Vested in three simple steps:

    • Click on Sign Up or Invest in ADVB stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Advanced Biomed Inc. Common Stock shares
    What is Advanced Biomed Inc. Common Stock 52-week high and low stock price?

    The 52-week high price of Advanced Biomed Inc. Common Stock (ADVB) is $4.1. The 52-week low price of Advanced Biomed Inc. Common Stock (ADVB) is $1.76.

    What is Advanced Biomed Inc. Common Stock price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Advanced Biomed Inc. Common Stock (ADVB) is 0.00

    What is the Market Cap of Advanced Biomed Inc. Common Stock?

    The market capitalization of Advanced Biomed Inc. Common Stock (ADVB) is $37.00M

    What is Advanced Biomed Inc. Common Stock’s stock symbol?

    The stock symbol (or ticker) of Advanced Biomed Inc. Common Stock is ADVB

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top